1-4 of 4
Antonios Bilalis
Close
Sort by
Journal Articles

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Clinical Trials & Observations
Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis, Eleni Plata, Konstantinos Varvagiannis, George Stamatopoulos, Klio Sinopoulou, Aggeliki Balassopoulou, Dimitris Loukopoulos, Evangelos Terpos
Journal: Blood
Blood (2010) 115 (12): 2354–2363.
https://doi.org/10.1182/blood-2009-05-221333
Published: 2010
Journal Articles

Prolonged Administration of Hydroxyurea Reduces Morbidity and Mortality in Adult Patients with Sickle-Cell Syndromes: Long-Term Experience of a Single Center.

Ersi Voskaridou, Antonios Bilalis, Dimitrios Christoulas, Konstantinos Varvagiannis, Kleio Sinopoulou, Eleni Plata, Panagiotis Tsaftaridis, Dimitris Loukopoulos, Evangelos Terpos
Journal: Blood
Blood (2008) 112 (11): 1445.
https://doi.org/10.1182/blood.V112.11.1445.1445
Published: 2008
Journal Articles

Deferasirox Reduces Serum TNF-α but Impairs Renal Function in Patients with Thalassemia Major after 12 Months of Therapy

Ersi Voskaridou, Eleni Plata, Dimitrios Christoulas, Charoula Xirakia, Eleni Stoupa, Konstantinos Varvagiannis, Antonios Bilalis, Athanasios Papatheodorou, Panagiotis Tsaftaridis, Evangelos Terpos
Journal: Blood
Blood (2008) 112 (11): 3888.
https://doi.org/10.1182/blood.V112.11.3888.3888
Published: 2008
Journal Articles

Serum Dickkopf-1 Is Increased and Correlates with Bone Mineral Density in Patients with Thalassemia-Induced Osteoporosis. Reduction Post Zoledronic Acid Administration

Ersi Voskaridou, Dimitrios Christoulas, Thodoris Pantelaros, Konstantinos Varvagiannis, Charoula Xirakia, Athanasios Papatheodorou, Kleio Sinopoulou, Aggeliki Mpalasopoulou, Antonios Bilalis, Evangelos Terpos
Journal: Blood
Blood (2008) 112 (11): 3889.
https://doi.org/10.1182/blood.V112.11.3889.3889
Published: 2008